tiprankstipranks
Trending News
More News >
Imugene (AU:IMU)
ASX:IMU

Imugene (IMU) Similar Shares

Compare
136 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Imugene
AU$0.32
$100.90M
-75.87%
1 Buy
0 Hold
0 Sell
Moderate Buy
Paradigm Biopharmaceuticals
AU$0.32
$134.98M
-17.11%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alterity Therapeutics
AU$0.01
AU$97.88M
0.00%
Prescient Therapeutics Limited
AU$0.09
AU$90.43M
-9.45
122.50%
Recce Pharmaceuticals Ltd.
AU$0.41
AU$167.73M
26.09%
Arovella Therapeutics Limited
AU$0.08
AU$106.68M
-13.09
-49.38%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:IMU
Imugene
0.32
-0.94
-74.56%
AU:PAR
Paradigm Biopharmaceuticals
0.32
-0.04
-11.27%
AU:ATH
Alterity Therapeutics
0.01
0.00
0.00%
AU:PTX
Prescient Therapeutics Limited
0.09
0.05
125.00%
AU:RCE
Recce Pharmaceuticals Ltd.
0.58
0.12
26.09%
AU:ALA
Arovella Therapeutics Limited
0.08
-0.10
-55.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts